Here’s what you should know:
1. Researchers are launching a randomized, double-blind, placebo-controlled clinical trial to test the effectiveness of Biomerica’s IBS therapy.
2. The InFoods IBS product allows physicians to identify specific foods that impact a patient’s IBD. If approved, physicians will be able to take a finger stick blood sample to find foods that impact IBS.
3. The study is being conducted at Boston-based Beth Israel Deaconess Medical Center and Ann Arbor-based University of Michigan.
4. The trial will include 180 patients and last up to 14 months.
5. The study results will be used in a FDA 510(k) application seeking FDA approval for the therapy.
More articles on gastroenterology:
TVA Medical to introduce FDA-approved endovascular fistula creation method at surgery centers — 5 insights
Implementing a total joint replacement program in your ASC: 4 lessons from OrthoIllinois Surgery Center
30k joint replacements for SurgCenter Development & more — 8 ASC company key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.